Back to Search
Start Over
Safety of statins: focus on clinical pharmacokinetics and drug interactions.
- Source :
-
Circulation [Circulation] 2004 Jun 15; Vol. 109 (23 Suppl 1), pp. III50-7. - Publication Year :
- 2004
-
Abstract
- Statin monotherapy is generally well tolerated, with a low frequency of adverse events. The most important adverse effects associated with statins are myopathy and an asymptomatic increase in hepatic transaminases, both of which occur infrequently. Because statins are prescribed on a long-term basis, however, possible interactions with other drugs deserve particular attention, as many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment. This review summarizes the pharmacokinetic properties of statins and emphasizes their clinically relevant drug interactions.
- Subjects :
- Binding, Competitive
Biological Availability
Calcium Channel Blockers pharmacokinetics
Chemical and Drug Induced Liver Injury
Citrus
Cytochrome P-450 CYP2D6 genetics
Cytochrome P-450 CYP3A
Cytochrome P-450 Enzyme Inhibitors
Cytochrome P-450 Enzyme System physiology
Drug Interactions
Fenofibrate pharmacokinetics
Gemfibrozil pharmacokinetics
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacokinetics
Liver Function Tests
Polymorphism, Genetic
Polymyositis chemically induced
Rhabdomyolysis chemically induced
Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1524-4539
- Volume :
- 109
- Issue :
- 23 Suppl 1
- Database :
- MEDLINE
- Journal :
- Circulation
- Publication Type :
- Academic Journal
- Accession number :
- 15198967
- Full Text :
- https://doi.org/10.1161/01.CIR.0000131519.15067.1f